Results 121 to 130 of about 41,567 (239)

From Mechanisms to Materials: Oximate Reactivity and Emerging Strategies for Organophosphate Detoxification

open access: yesChemPhysChem, Volume 27, Issue 7, 14 April 2026.
The development of effective strategies for the detoxification of organophosphorus (OP) nerve agents has evolved from the early mechanistic studies of François Terrier and collaborators, who first elucidated the exceptional nucleophilicity of α‐effect species such as oximes and hydroxamates, to the modern design of supramolecular and material‐based ...
Pedro Rodríguez‐Dafonte
wiley   +1 more source

Ocular surface alterations in agricultural workers exposed to pesticides in Cundinamarca, Colombia

open access: yesJFO Open Ophthalmology
Background: The cholinergic system regulates a variety of structures on the ocular surface and maintains homeostasis. Therefore, dysregulation of cholinergic activity could impact lacrimal and conjunctival function.
Yuly-N. Franco   +5 more
doaj   +1 more source

Two cases of Alzheimer's disease showing deterioration of behavioral and psychological symptoms of dementia induced by switching from rivastigmine to donepezil

open access: yesNeuropsychiatric Disease and Treatment, 2012
Takemi Kimura, Junichi TakamatsuDivision of Clinical Research, National Hospital Organization Kikuchi Hospital, Koshi, Kumamoto, JapanAbstract: Rivastigmine, galantamine, and memantine, in addition to donepezil, which has been on the market over 10 years,
Kimura T, Takamatsu J
doaj  

Aktivnost kolinesteraza u punoj ljudskoj krvi mjerena acetiltiokolinom kao supstratom i etopropazinom kao selektivnim inhibitorom butirilkolinesteraze u plazmi [PDF]

open access: yes, 2004
A procedure is suggested for measuring acetylcholinesterase and butyrylcholinesterase activities in human whole blood using acetylthiocholine as a substrate and ethopropazine as a selective inhibitor of butyrylcholinesterase.
Anita Bosak   +2 more
core   +1 more source

Cholinesterase inhibitors for patients with dementia: Patterns of prescribing and disparities in treatment. [PDF]

open access: yesJ Alzheimers Dis
Heo RJ   +8 more
europepmc   +2 more sources

Cholinesterase Inhibitors [PDF]

open access: yes, 2018
Stephanie Behrens, JoAnn Tschanz
openaire   +1 more source

New benzimidazole-alkanesulfonate conjugates as cholinesterase inhibitors with in vitro and in silico validation. [PDF]

open access: yesSci Rep
Omar MA   +5 more
europepmc   +1 more source

Isolation, Identification and In Silico Evaluation of Novel Cholinesterase Inhibitors from <i>Terminalia triptera</i> Stapf. [PDF]

open access: yesMolecules
Phan TQ   +8 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy